Development of an intranasal COVID-19 vaccine that exploits SARS-CoV-2 Virus-like Particles

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/2010/31/21

Funding

  • The Mercatus Center at George Mason University: $200,000.00